These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15298630)

  • 1. Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs.
    Rubenstein JH; Laine L
    Aliment Pharmacol Ther; 2004 Aug; 20(4):373-80. PubMed ID: 15298630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of non-steroidal anti-inflammatory drugs in acute liver injury.
    García Rodríguez LA; Pérez Gutthann S; Walker AM; Lueck L
    BMJ; 1992 Oct; 305(6858):865-8. PubMed ID: 1422399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs.
    Pérez Gutthann S; García Rodríguez LA
    Epidemiology; 1993 Nov; 4(6):496-501. PubMed ID: 8268277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.
    Traversa G; Bianchi C; Da Cas R; Abraha I; Menniti-Ippolito F; Venegoni M
    BMJ; 2003 Jul; 327(7405):18-22. PubMed ID: 12842950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
    Hippisley-Cox J; Coupland C; Logan R
    BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory Drugs.
    Meunier L; Larrey D
    Ann Hepatol; 2018 Mar; 17(2):187-191. PubMed ID: 29469052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
    Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW;
    Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.
    Aithal GP; Day CP
    Clin Liver Dis; 2007 Aug; 11(3):563-75, vi-vii. PubMed ID: 17723920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs.
    Lee CH; Wang JD; Chen PC
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):708-14. PubMed ID: 20582911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
    Lapeyre-Mestre M; de Castro AM; Bareille MP; Del Pozo JG; Requejo AA; Arias LM; Montastruc JL; Carvajal A
    Fundam Clin Pharmacol; 2006 Aug; 20(4):391-5. PubMed ID: 16867024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity of nonsteroidal anti-inflammatory drugs.
    Rabinovitz M; Van Thiel DH
    Am J Gastroenterol; 1992 Dec; 87(12):1696-704. PubMed ID: 1449128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug-induced hepatoxicity.
    Unzueta A; Vargas HE
    Clin Liver Dis; 2013 Nov; 17(4):643-56, ix. PubMed ID: 24099022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?
    Bessone F
    World J Gastroenterol; 2010 Dec; 16(45):5651-61. PubMed ID: 21128314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity of non-narcotic analgesics.
    Tolman KG
    Am J Med; 1998 Jul; 105(1B):13S-19S. PubMed ID: 9715830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs.
    Teoh NC; Farrell GC
    Clin Liver Dis; 2003 May; 7(2):401-13. PubMed ID: 12879991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom.
    García Rodríguez LA; Ruigómez A; Jick H
    Pharmacotherapy; 1997; 17(4):721-8. PubMed ID: 9250549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular damage from non-steroidal anti-inflammatory drugs.
    O'Connor N; Dargan PI; Jones AL
    QJM; 2003 Nov; 96(11):787-91. PubMed ID: 14566034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis.
    Dezateux C; Crighton A
    Cochrane Database Syst Rev; 2000; (2):CD001505. PubMed ID: 10796797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.